Information Density: Hansaplast – Signal Evidence & AI Readability

Hansaplast

(https://hansaplast.com) 📸 Data Snapshot: May 30, 2026
Information Density — The Lens

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Info Density Power-words vs. Substance ratio.
15 Impact Weight: 30 / 100
50% Reputation

The page exhibits a high ratio of navigational fluff to substantive content. While the H1 ‘Welcome to our consumer markets’ avoids standard power-word jargon, the body substance ratio is poor as it contains zero technical specifications, medical claims, or outcome data, resulting in 10 points for body fluff. Specificity is almost entirely absent, with no mention of GMP compliance, ISO certifications, or product materials, earning 5 points for specificity absence.

Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.

📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://hansaplast.com) Please select a local market website
[H1] Welcome to our consumer markets

Please select your country

Africa

South Africa

Asia & Oceania

India

Malaysia

Middle East

Singapore

Australia

Indonesia

Global

Global

Americas

Canada

Canada

México

Argentina

América Latina

Europe

Österreich

ABC Österreich

Belgique

België

Hrvatska

Danmark

Suomi

Elastoplast France

Deutschland

ABC Deutschland

Ελλάδα

Italia

Nederland

Portugal

España, alfabetización internacional

Sverige

Schweiz

Suisse

United Kingdom
1088 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…